NCT00296309View on ClinicalTrials.gov

Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.

PHASE3CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Kidney Transplantation
Interventions
DRUG

Tacrolimus

Immunosuppression

Trial Locations (33)

1200

Brussels

3000

Leuven

3508

Utrecht

8091

Zurich

10117

Berlin

18057

Rostock

23562

Lübeck

28007

Madrid

28041

Madrid

30625

Hanover

31059

Toulouse

33076

Bordeaux

34295

Montpellier

37044

Tours

39008

Santander

45122

Essen

48149

Münster

50931

Cologne

51109

Cologne

54511

Vandœuvre-lès-Nancy

63003

Clermont-Ferrand

79106

Freiberg

81675

München

92151

Suresnes

94010

Créteil

94275

Le Kremlin-Bicêtre

06002

Nice

06120

Halle

07747

Jena

04103

Leipzig

BT9 7AB

Belfast

CB2 2QQ

Cambridge

NG5 1PB

Nottingham

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Europe B.V.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00296309 - Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation. | Biotech Hunter | Biotech Hunter